You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Pulmonology
On demand events

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz and Mona Bafadhel for an educational symposium exploring the role of type 2 cytokines in COPD and delve into the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden.

Henrik Watz
Mona Bafadhel
MD, PhD
Henrik Watz +1 more

On demand materials

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation
Pulmonology
expert video

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden
Pulmonology
expert video

ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden

ERS 2024 | Unraveling the Role of Type 2 Inflammation in COPD
Pulmonology
expert video

ERS 2024 | Unraveling the Role of Type 2 Inflammation in COPD

Learning objectives

  • Link the underlying drivers of COPD with type 2 inflammation to cumulative patient burden
  • Communicate the differential roles of type 2 cytokines and mediators as markers or drivers of disease in COPD with type 2 inflammation
Tags
symposium
MAT-US-2410774 v1.0 - P Exp Date: 10/28/2026

About these experts

Pulmonology
MD, PhD

Henrik Watz

Professor, University of Kiel, Kiel, Germany | Medical Director, Velocity Clinical Research Grosshansdorf, Grosshansdorf, Germany

Pulmonology
MD, PhD

Mona Bafadhel

Chair of Respiratory Medicine Director of the King’s Centre for Lung Health

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region